BCBA/BAYN (BCBA/BAYN)

Buenos Aires Stock Exchange: BCBA/BAYN · ARS

ARS 26,500

+100.32 (+0.4%)· Recorded snapshot

Market cap	77.5T
Revenue (ttm)	76.8T
Net income (ttm)	-2.9T
EPS (ttm)	-ARS 1,013
P/E (forward)	9.8x
Dividend	ARS 40.4 (0.15%)
Volume	5

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 76.8T
Net income (ttm): -2.9T
EPS (ttm): -ARS 1,013
P/E (forward): 9.8x
Market cap: 77.5T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 13:30 UTC

Forward P/E9.8

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-5.7

P25 n/aP50 n/aP75 n/a

ROIC8.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BCBA/BAYN indicators

Market & fundamental data

Available fields

185

Groups with data

Currency

EUR

Showing 185 of 185 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	ARS
Country	Germany
Country code	AR
Earnings date	2026-11-03
Employees	87,830
Employees change	-1,726
Employees growth	-1.93%
Enterprise value	ARS 134.8T
Exchange	Buenos Aires Stock Exchange
Financial currency	EUR
Financial report date	2026-06-30
First seen	2026-08-17
Fiscal year end	December
Founded	1863
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	ARDEUT112414
Last refreshed	2026-10-29
Market cap	ARS 77.5T
Next earnings date	2026-11-03
Price	ARS 26,500.00
Price currency	ARS
Sector	Healthcare
SIC code	2800
Stock price date	2026-10-28
Symbol	bcba/BAYN
Website	https://www.bayer.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-3.82%
EV/EBIT	14.66x
EV/EBITDA	7.55x
EV/FCF	38.34x
EV/Sales	1.73x
FCF / EV yield	2.61%
FCF yield	4.54%
Forward P/E	9.8x
P/B ratio	1.54x
P/FCF ratio	22.03x
P/OCF ratio	9.57x
P/S ratio	1.01x
Price/EBITDA ratio	4.52x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	11.93%
EBITDA margin	22.33%
FCF margin	4.51%
Gross margin	60.46%
Operating margin	11.93%
Pretax margin	-2.7%
Profit margin	-3.83%
Profit per employee	ARS -33.5M
Profitable quarters	2
Revenue per employee	ARS 874.4M
ROA	3.18%
ROA (5Y)	3.38%
ROCE	7.21%
ROE	-5.69%
ROE (5Y)	-2.72%
ROIC	8.71%
ROIC (5Y)	8.24%
Tax / revenue	1.08%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth (QoQ)	-92.07%
EPS growth quarters	2
EPS growth years	0
FCF growth	-54.77%
FCF growth (Q)	-94.94%
Gross profit growth	7.97%
Gross profit growth (Q)	5.65%
Gross profit growth 3Y	-2.63%
Gross profit growth 5Y	1.54%
Net income growth (QoQ)	-92.07%
Net income growth quarters	2
Net income growth years	0
OCF growth	-33.11%
OCF growth (Q)	-34.78%
OCF growth 10Y	-4.41%
OCF growth 3Y	21.77%
OCF growth 5Y	19.66%
Operating income growth	99.96%
Operating income growth (Q)	0.5%
Operating income growth 3Y	-10.73%
Operating income growth 5Y	-12.08%
Revenue growth	-1.73%
Revenue growth (Q)	1.24%
Revenue growth (QoQ)	-18.9%
Revenue growth 10Y	1.23%
Revenue growth 3Y	-2.34%
Revenue growth 5Y	1.71%
Revenue growth quarters	1
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	ARS -4.6T
Depreciation and amortization	ARS 8.1T
EBIT	ARS 9.2T
EBITDA	ARS 17.2T
EPS	ARS -1,013.16
Financing cash flow	ARS -5.3T
Free cash flow	ARS 3.5T
Gross profit	ARS 46.4T
Income taxes	ARS 829.4B
Investing cash flow	ARS -3.4T
Net borrowing	ARS -2.3T
Net cash flow	ARS -453.6B
Net income	ARS -2.9T
Operating income	ARS 9.2T
Revenue	ARS 76.8T

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	ARS 50,968.80
Debt / EBITDA	3.67
Debt / equity	1.29
Debt / FCF	18.49
Goodwill	ARS 49.4T
Interest coverage	2.71
Long-term assets	ARS 123.8T
Long-term liabilities	ARS 75.9T
Net cash (debt)	ARS -56.4T
Net cash / market cap	-72.84%
Net debt / EBITDA	3.29
Net debt / equity	1.12
Net debt / FCF	16.05
Piotroski F-Score	6
Property, plant and equipment	ARS 21.9T
Shareholders' equity	ARS 50.3T
Tangible book value	ARS -33.5T
Tangible book value per share	ARS -34,065.92
Total assets	ARS 181.6T
Total cash	ARS 8.6T
Total debt	ARS 65T
Total liabilities	ARS 131.3T

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.43
Current assets	ARS 57.8T
Current liabilities	ARS 55.4T
Current ratio	1.04
Inventory turnover	1.49
Net working capital	ARS 6T
Quick ratio	0.67
Working capital	ARS 2.3T
Working capital turnover	28,731.77

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend growth	26.15%
Dividend growth (10Y)	-3.09%
Dividend growth (3Y)	-34.36%
Dividend growth (5Y)	-6.08%
Dividend growth years	1
Dividend payment date	2026-04-29
Dividend payment years	5
Dividend payout frequency	Annual
Dividend per share	ARS 40.36
Dividend yield	0.15%
Ex-dividend date	2026-04-28
Last dividend	ARS 40.36
Shareholder yield	0.15%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1D price change	0.38%
1M price change	-11.67%
1M total return	-11.67%
1W price change	-9.56%
1W total return	-9.56%
20-day SMA	ARS 29,362.00
52-week high	ARS 33,000.00
52-week high date	2026-09-11
52-week low	ARS 26,000.00
52-week low date	2026-08-13
All-time high	ARS 33,000.00
All-time high date	2026-08-13
All-time low	ARS 26,000.00
All-time low date	2026-08-13
Average true range (ATR)	ARS 1,107.37
Average volume	65.2
Change from 52-week high	-19.7%
Change from 52-week low	1.92%
Change from all-time high	-19.7%
Change from all-time low	1.92%
Change from open	0.38%
Day's gap	0%
Dollar volume	ARS 132,500
High price	ARS 26,500.00
Low price	ARS 26,400.00
Monthly RSI	0
Open price	ARS 26,400.00
Position in 52-week range	100%
Previous close	ARS 26,400.00
Price vs 20-day SMA	-9.75%
Relative volume	0.08
RSI	35.21
Sharpe ratio	-0.8
Sortino ratio	-1.06
Volume	5
Weekly RSI	0

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	982.4M
Shares change (QoQ)	0%
Shares held by institutions	39.31%

Deeper analysis on BCBA/BAYN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BCBA/BAYN report

Is a complete BCBA/BAYN research report available?

No complete published report is available for bcba/BAYN (BCBA/BAYN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BCBA/BAYN (BCBA/BAYN)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/BAYN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/BAYN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/BAYN

Frequently asked questions